RARE ALERT: Teva said be planning on submitting formal $43 billion takeover bid this weekend

Readers might be scratching their heads, wondering why Teva still hasn't announced a formal offer for rival pharmaceutical company Mylan despite reports from Bloomberg and the Financial Times this week revealing the Israeli company is was preparing to submit a formal offer of between $86 and $88 a share...